Innoviva (INVA) Tops Q2 EPS by 31c
Tweet
Share
E-mailGet Alerts INVA Hot Sheet
Join SI Premium – FREE
Innoviva (NASDAQ: INVA) reported Q2 EPS of $0.77, $0.31 better than the analyst estimate of $0.46. Revenue for the quarter came in at $100.28 million versus the consensus estimate of $90.59 million.
For earnings history and earnings-related data on Innoviva (INVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Barclays Starts SAB Biotherapeutics (SABS) at Overweight
- Global S&P Futures mixed in premarket
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
